You are here: Industry Insights > Treatment

News List

FDA Expands Approval of Cystic Fibrosis Treatment americanpharmaceuticalreview
June 26, 2019
The U.S. Food and Drug Administration (FDA) expanded the indication for Symdeko (a combination of tezacaftor/ivacaftor) tablets for treatment of pediatric patients ages 6 years and older with cystic fibrosis who have certain genetic mutations.
Ziopharm Oncology Achieves Positive Results for Glioblastoma Treatment contractpharma
June 19, 2019
Controlled IL-12 platform appears to have activity as a monotherapy and is now being studied in an expanded group of patients.
Perfect Teeth Won't Guarantee a Perfect Life drugs
June 19, 2019
Perfect Teeth Won't Guarantee a Perfect Life.
Aclaris Therapeutics Submits IND for RA Treatment contractpharma
June 14, 2019
If the IND is allowed by the FDA, Aclaris plans to initiate a Phase 1 trial of ATI-450, an oral MK2 inhibitor in 2H19
Amyloidosis treatment discontinued from clinical trials europeanpharmaceuticalreview
June 11, 2019
A treatment for amyloidosis has been pulled from clinical trials after failing to reach endpoints.
FDA Approves Treatment for Hospital-Acquired, Ventilator-Associated Bacterial Pneumonia americanpharmaceuticalreview
June 06, 2019
The U.S. Food and Drug Administration (FDA) approved a new indication for the previously FDA-approved drug, Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP
FDA Approves First Treatment for Episodic Cluster Headache to Reduce Frequency americanpharmaceuticalreview
June 06, 2019
The U.S. Food and Drug Administration (FDA) approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults.
Few Prostate Cancer Patients Are Getting Checkups They Need drugs
June 06, 2019
Few Prostate Cancer Patients Are Getting Checkups They Need.
'Secret Shopper' Study Finds Many Who Need Addiction Treatment Can't Get It drugs
June 05, 2019
When people who are addicted to opioids make the difficult decision to quit, the last thing they need to face are barriers to treatment.
Esketamine Nasal Spray May Improve Refractory Depression Outcomes drugs
June 03, 2019
Esketamine Nasal Spray May Improve Refractory Depression Outcomes.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page